These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 31817940)

  • 1. Systemic Sclerosis Serum Significantly Impairs the Multi-Step Lymphangiogenic Process: in Vitro Evidence.
    Manetti M; Romano E; Rosa I; Fioretto BS; Guiducci S; Bellando-Randone S; Pigatto E; Cozzi F; Ibba-Manneschi L; Matucci-Cerinic M
    Int J Mol Sci; 2019 Dec; 20(24):. PubMed ID: 31817940
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systemic Sclerosis Sera Impair Angiogenic Performance of Dermal Microvascular Endothelial Cells: Therapeutic Implications of Cyclophosphamide.
    Borghini A; Manetti M; Nacci F; Bellando-Randone S; Guiducci S; Matucci-Cerinic M; Ibba-Manneschi L; Weber E
    PLoS One; 2015; 10(6):e0130166. PubMed ID: 26076019
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence for a Derangement of the Microvascular System in Patients with a Very Early Diagnosis of Systemic Sclerosis.
    Chora I; Romano E; Manetti M; Mazzotta C; Costa R; Machado V; Cortez A; Bruni C; Lepri G; Guiducci S; De Paulis A; Soares R; Matucci-Cerinic M
    J Rheumatol; 2017 Aug; 44(8):1190-1197. PubMed ID: 28507177
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decreased expression of neuropilin-1 as a novel key factor contributing to peripheral microvasculopathy and defective angiogenesis in systemic sclerosis.
    Romano E; Chora I; Manetti M; Mazzotta C; Rosa I; Bellando-Randone S; Blagojevic J; Soares R; Avouac J; Allanore Y; Ibba-Manneschi L; Matucci-Cerinic M; Guiducci S
    Ann Rheum Dis; 2016 Aug; 75(8):1541-9. PubMed ID: 26359450
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppression of lymphangiogenesis in human lymphatic endothelial cells by simultaneously blocking VEGF-C and VEGF-D/VEGFR-3 with norcantharidin.
    Liu ZY; Qiu HO; Yuan XJ; Ni YY; Sun JJ; Jing W; Fan YZ
    Int J Oncol; 2012 Nov; 41(5):1762-72. PubMed ID: 22922710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proangiogenic effects of soluble α-Klotho on systemic sclerosis dermal microvascular endothelial cells.
    Mazzotta C; Manetti M; Rosa I; Romano E; Blagojevic J; Bellando-Randone S; Bruni C; Lepri G; Guiducci S; Ibba-Manneschi L; Matucci-Cerinic M
    Arthritis Res Ther; 2017 Feb; 19(1):27. PubMed ID: 28183357
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting VEGFR-3/-2 signaling pathways with AD0157: a potential strategy against tumor-associated lymphangiogenesis and lymphatic metastases.
    García-Caballero M; Paupert J; Blacher S; Van de Velde M; Quesada AR; Medina MA; Noël A
    J Hematol Oncol; 2017 Jun; 10(1):122. PubMed ID: 28629427
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of Lymphangiogenic Factors With Pulmonary Arterial Hypertension in Systemic Sclerosis.
    Didriksen H; Molberg Ø; Fretheim H; Gude E; Jordan S; Brunborg C; Palchevskiy V; Garen T; Midtvedt Ø; Andreassen AK; Distler O; Belperio J; Hoffmann-Vold AM
    Arthritis Rheumatol; 2021 Jul; 73(7):1277-1287. PubMed ID: 33497027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of VEGF165b, an inhibitory splice variant of vascular endothelial growth factor, leads to insufficient angiogenesis in patients with systemic sclerosis.
    Manetti M; Guiducci S; Romano E; Ceccarelli C; Bellando-Randone S; Conforti ML; Ibba-Manneschi L; Matucci-Cerinic M
    Circ Res; 2011 Jul; 109(3):e14-26. PubMed ID: 21636803
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vascular endothelial growth factor-C secreted by pancreatic cancer cell line promotes lymphatic endothelial cell migration in an in vitro model of tumor lymphangiogenesis.
    Ochi N; Matsuo Y; Sawai H; Yasuda A; Takahashi H; Sato M; Funahashi H; Okada Y; Manabe T
    Pancreas; 2007 May; 34(4):444-51. PubMed ID: 17446844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Collaborative interplay between FGF-2 and VEGF-C promotes lymphangiogenesis and metastasis.
    Cao R; Ji H; Feng N; Zhang Y; Yang X; Andersson P; Sun Y; Tritsaris K; Hansen AJ; Dissing S; Cao Y
    Proc Natl Acad Sci U S A; 2012 Sep; 109(39):15894-9. PubMed ID: 22967508
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuropilin-2 contributes to LPS-induced corneal inflammatory lymphangiogenesis.
    Tang X; Sun J; Du L; Du H; Wang L; Mai J; Zhang F; Liu P
    Exp Eye Res; 2016 Feb; 143():110-9. PubMed ID: 26500194
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plexin-D1/Semaphorin 3E pathway may contribute to dysregulation of vascular tone control and defective angiogenesis in systemic sclerosis.
    Mazzotta C; Romano E; Bruni C; Manetti M; Lepri G; Bellando-Randone S; Blagojevic J; Ibba-Manneschi L; Matucci-Cerinic M; Guiducci S
    Arthritis Res Ther; 2015 Aug; 17(1):221. PubMed ID: 26292963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A potential small-molecule synthetic antilymphangiogenic agent norcantharidin inhibits tumor growth and lymphangiogenesis of human colonic adenocarcinomas through blocking VEGF-A,-C,-D/VEGFR-2,-3 "multi-points priming" mechanisms in vitro and in vivo.
    Li XP; Jing W; Sun JJ; Liu ZY; Zhang JT; Sun W; Zhu W; Fan YZ
    BMC Cancer; 2015 Jul; 15():527. PubMed ID: 26187792
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bone marrow-derived mesenchymal stem cells from early diffuse systemic sclerosis exhibit a paracrine machinery and stimulate angiogenesis in vitro.
    Guiducci S; Manetti M; Romano E; Mazzanti B; Ceccarelli C; Dal Pozzo S; Milia AF; Bellando-Randone S; Fiori G; Conforti ML; Saccardi R; Ibba-Manneschi L; Matucci-Cerinic M
    Ann Rheum Dis; 2011 Nov; 70(11):2011-21. PubMed ID: 21821866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The tyrosine kinase inhibitor cediranib blocks ligand-induced vascular endothelial growth factor receptor-3 activity and lymphangiogenesis.
    Heckman CA; Holopainen T; Wirzenius M; Keskitalo S; Jeltsch M; Ylä-Herttuala S; Wedge SR; Jürgensmeier JM; Alitalo K
    Cancer Res; 2008 Jun; 68(12):4754-62. PubMed ID: 18559522
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mobilization of lymphatic endothelial precursor cells and lymphatic neovascularization in primary Sjögren's syndrome.
    Alunno A; Ibba-Manneschi L; Bistoni O; Rosa I; Caterbi S; Gerli R; Manetti M
    J Cell Mol Med; 2016 Apr; 20(4):613-22. PubMed ID: 26828975
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NRP-2 in tumor lymphangiogenesis and lymphatic metastasis.
    Wang J; Huang Y; Zhang J; Xing B; Xuan W; Wang H; Huang H; Yang J; Tang J
    Cancer Lett; 2018 Apr; 418():176-184. PubMed ID: 29339213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular controls of lymphatic VEGFR3 signaling.
    Deng Y; Zhang X; Simons M
    Arterioscler Thromb Vasc Biol; 2015 Feb; 35(2):421-9. PubMed ID: 25524775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Scleroderma dermal microvascular endothelial cells exhibit defective response to pro-angiogenic chemokines.
    Tsou PS; Rabquer BJ; Ohara RA; Stinson WA; Campbell PL; Amin MA; Balogh B; Zakhem G; Renauer PA; Lozier A; Arasu E; Haines GK; Kahaleh B; Schiopu E; Khanna D; Koch AE
    Rheumatology (Oxford); 2016 Apr; 55(4):745-54. PubMed ID: 26705326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.